US-based medical device company and producer of the NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses Visioneering Technologies, Inc (ASX: VTI) (‘Visioneering’ or ‘The Company’) has announced its launch into the UK.
Atlanta, Georgia, 20 February 2019: US-based medical device company and producer of the NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses Visioneering Technologies, Inc (ASX: VTI) (‘Visioneering’ or ‘The Company’) has announced its launch into the UK.
To read the United Kingdom Launch ASX announcement, please click here
To read the Change of Company Secretary ASX announcement, please click here
Learn more about Visioneering Technologies from our videos:
Click here to watch Dr Stephen Snowdy outline our investor presentation
Click here to watch Visioneering Technologies on Today Show
Click here to watch Dr Stephen Snowdy highlight our business
Company Enquiries
Dr Stephen Snowdy
Visioneering Technologies, Inc.
E: investors@vtivision.com
Media Enquiries
Julia Maguire
The Capital Network
E: julia@thecapitalnetwork.com.au
T: +61 419 815 386
About Visioneering Technologies, Inc.
Visioneering Technologies, Inc. (ASX:VTI) is a US-based medical device company primarily engaged in the design, manufacture, sale and distribution of a revolutionary new contact lens: the NaturalVue Multifocal (MF) contact lense. The NaturalVue MF contact lens employs VTI's Neurofocus Optics technology, which was developed, refined and tested over many years. The characteristics of the NaturalVue MF contact lens allow it to be used in two of the largest eye-care markets globally: adults with presbyopia (age-related difficulty in seeing close objects) and children with myopia (near-sightedness, or difficulty seeing distant objects).
NaturalVue lenses were cleared by the FDA in late 2014 and received the CE Mark, as well as TGA approval in early 2018. VTI recently commenced its US market expansion for NaturalVue MF contact lenses, and has broadened its reach into international markets in 2018. VTI also sells and plans additional contact lens products.
